Results 51 to 60 of about 13,629,588 (389)

Monitoring of Sotrovimab-Levels as Pre-Exposure Prophylaxis in Kidney Transplant Recipients Not Responding to SARS-CoV-2 Vaccines

open access: yesViruses, 2023
Background Sotrovimab, a monoclonal antibody against SARS-CoV-2, is used as a pre-exposition prophylaxis (PrEP) against COVID-19, but monitoring strategies using routine test systems have not been defined.
Constantin Aschauer   +11 more
doaj   +1 more source

Characterization of a Second Bovine Rotavirus Serotype [PDF]

open access: yes, 1987
Bovine rotavirus (BRV) V 1005 was characterized by two-way cross-neutralization tests as a second serotype of BRV. Virions and inner shell particles of 65 nm and 55 nm diameter respectively, and empty capsids of 65 nm and 55 nm diameter were separated by
Büssow, Harald   +4 more
core   +1 more source

Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection

open access: yesVaccines, 2023
Herein, we review established clinical use cases for SARS-CoV-2 antibody measures, which include diagnosis of recent prior infection, isolating high titer convalescent plasma, diagnosing multisystem inflammatory syndrome in children (MIS-C), and booster ...
Kimia Sobhani   +14 more
doaj   +1 more source

Identification of a protein encoded in the EB-viral open reading frame BMRF2 [PDF]

open access: yes, 1992
Using monospecific rabbit sera against a peptide derived from a potential antigenic region of the Epstein-Barr viral amino acid sequence encoded in the open reading frame BMRF2 we could identify a protein-complex of 53/55 kDa in chemically induced B95-8,
A. v. Brunn   +37 more
core   +2 more sources

A single, continuous metric to define tiered serum neutralization potency against HIV

open access: yeseLife, 2018
HIV-1 Envelope (Env) variants are grouped into tiers by their neutralization-sensitivity phenotype. This helped to recognize that tier 1 neutralization responses can be elicited readily, but do not protect against new infections.
Peter Hraber   +4 more
doaj   +1 more source

IgG antibodies against phospholipase A2 from Crotalus durissus terrificus: cross-reaction with venoms from Bothrops species from Argentina

open access: yesJournal of Venomous Animals and Toxins including Tropical Diseases, 2009
We examined the ability of IgG anti-crotalic PLA2 to cross-react with Bothrops spp. venoms, from snakes found in the northeast of Argentina. Immunoblotting and ELISA tests showed that IgG anti-crotalic PLA2 recognize antigens of bothropic venoms ...
JP Rodríguez   +6 more
doaj   +1 more source

Antigenic relationships among certain arthropod-borne viruses as revealed by neutralization tests.

open access: yesJournal of Immunology, 1954
The problem of interrelationships among arthropod-borne viruses which are neurotropic for Swiss mice was attacked from 4 avenues of approach. Cross-neutralization tests with univalent laboratory-produced monkey antisera and 23 different viruses ...
K. C. Smithburn
semanticscholar   +1 more source

Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future [PDF]

open access: yes, 2014
Serological techniques commonly used to quantify influenza-specific antibodies include the Haemagglutination Inhibition (HI), Single Radial Haemolysis (SRH) and Virus Neutralization (VN) assays.
Callow   +30 more
core   +3 more sources

Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea

open access: yesEmerging Infectious Diseases, 2015
We investigated the kinetics of serologic responses to Middle East respiratory syndrome coronavirus (MERS-CoV) infection by using virus neutralization and MERS-CoV S1 IgG ELISA tests.
Wan Beom Park   +15 more
doaj   +1 more source

A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses

open access: yesViruses, 2023
The henipaviruses, Nipah virus (NiV), and Hendra virus (HeV) can cause fatal diseases in humans and animals, whereas Cedar virus is a nonpathogenic henipavirus.
Moushimi Amaya   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy